Pfizer PFE stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since mid-August The 50-day moving average is a short-term indicator, while the 200-day moving average is a ...

Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...

Pfizer’s PFE stock has declined 10.7% so far this year compared with a decrease of 7.7% for the industry. The stock has also underperformed the sector and the S&P 500, as seen in the chart below. The ...

Pfizer has beaten its earnings per share (EPS) estimates in its past 12 quarters. Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ...

Pfizer is one of the world's largest pharmaceutical companies. Even after losing more than half of its value, it still has a ...